The Wellcome Genome Campus in association with Nature Genetics is pleased to announce the 11th annual Genomics of Common Diseases (GCD) conference, which will commence on September 6 – 9, 2017 at our headquater in Hinxton, UK. This year we have an exciting programme focused on emerging technologies that are providing fundamental insights into human diseases with direct links to the development of clinical therapies.
There is a growing use of genomic tools for making clinical decisions; its contribution is likely to increase significantly in the near future. To accelerate this progress, further work is needed to characterise new disease mechanisms and to identify innovative approaches for data mining and drug therapeutic targeting. This conference will provide an excellent platform for scientists moving from GWAS into biological function and disease mechanisms. The meeting will highlight leading examples of using deep genome sequencing and direct genome engineering (e.g. CRISPR) to discover genes and to enhance functional annotation.
The programme will feature recent advances in analytical tools to detect polygenic susceptibility and its genetic implications for drug therapeutic targeting. We will also discuss the growing use and current challenges of merging electronic health records along with genomic data in clinical practice.
This event will bring together a multi-disciplinary group of clinicians, research scientists, bioinformaticians and technology developers interested in using genomic advances to develop and deliver therapies for patients with common diseases (e.g. cancer, autoimmunity, brain disorders, endocrine and cardiovascular diseases, among others).
We also are pleased to announce a joint symposium titled “Big Data Analytics for Genetics in Personalised Medicine” in association with the GCD committee, Nature Genetics and the International Genetic Epidemiology Society (IGES) committee. The joint symposium will focus on recent developments in analytical tools and resources that are facilitating big data integration, exploration and usage in medicine. It will follow on directly after the GCD conference.
Topics will include:
- Identifying novel genes and pathways
- Genome engineering (e.g. CRISPR)
- Innovative approaches to complex trait analysis
- Regulatory variation of complex human diseases
- Advances in large-scale functional annotation
- Using human genetics to inform drug development
- Bringing genomics into clinical use
Bursary deadline: 27 June 2017
A limited number of registration bursaries are available for PhD students to attend this conference (up to 50% of the registration fee) from Wellcome Genome Campus Scientific Conferences.
The following documents will need to be provided:
- Abstract, CV
- Covering letter
- Letter from supervisor
To apply, please contact the conference organiser.
Scientific programme committee
- Orli Bahcall – Nature, USA
- Peter Campbell – Wellcome Trust Sanger Institute, UK
- Aravinda Chakravarti – Johns Hopkins University School of Medicine, USA
- Sekar Kathiresan – Massachusetts General Hospital, USA
- Teri Manolio – National Human Genome Research Institute, USA
- Nicole Soranzo – Wellcome Trust Sanger Institute, UK
- Kyle Vogan – Nature Genetics, USA
- Laura Hubbard – Wellcome Genome Campus, UK